Drug intelligence / Profile preview

indapamide + hydrochlorothiazide

Development stage
Unknown
Lead developer
Sanofi
Modality
Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Indapamide + hydrochlorothiazide is a combination of two diuretic medications used to manage hypertension and fluid retention. Both drugs act on the distal convoluted tubule of the nephron in the kidney, promoting increased excretion of sodium and water, which reduces blood volume and lowers blood pressure. Indapamide is classified as a thiazide-like diuretic, while hydrochlorothiazide is a thiazide-type diuretic. The combination may be considered for patients who require enhanced diuresis or antihypertensive effect; however, clinical guidelines generally advise against using both simultaneously due to overlapping mechanisms and increased risk of adverse effects such as hypokalemia[3][7]. Each agent has demonstrated efficacy in lowering blood pressure and reducing cardiovascular risk when used alone or with other antihypertensives[1][2][7].

02

Targets

SLC12A3 (Thiazide-sensitive sodium-chloride cotransporter)

Beyond the preview

Go deeper on indapamide + hydrochlorothiazide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on indapamide + hydrochlorothiazide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call